Germany · Delayed Price · Currency is EUR genedrive Statistics
Total Valuation
genedrive has a market cap or net worth of EUR 11.71 million. The enterprise value is 9.33 million.
| Market Cap | 11.71M |
| Enterprise Value | 9.33M |
Important Dates
The last earnings date was Friday, November 28, 2025.
| Earnings Date | Nov 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 1.03B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +271.64% |
| Shares Change (QoQ) | +172.96% |
| Owned by Insiders (%) | 8.06% |
| Owned by Institutions (%) | 78.89% |
| Float | 798.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.80 |
| PB Ratio | 3.15 |
| P/TBV Ratio | 3.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.05 |
| EV / Sales | 13.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.72 |
Financial Position
The company has a current ratio of 4.13
| Current Ratio | 4.13 |
| Quick Ratio | 3.73 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,380.73 |
Financial Efficiency
Return on equity (ROE) is -321.90% and return on invested capital (ROIC) is -146.73%.
| Return on Equity (ROE) | -321.90% |
| Return on Assets (ROA) | -92.73% |
| Return on Invested Capital (ROIC) | -146.73% |
| Return on Capital Employed (ROCE) | -179.90% |
| Revenue Per Employee | 17,239 |
| Profits Per Employee | -207,117 |
| Employee Count | 43 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 9.63 |
Taxes
| Income Tax | -634,848 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.04% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -13.04% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 51.97 |
| Average Volume (20 Days) | 14,415 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, genedrive had revenue of EUR 741,261 and -8.91 million in losses. Loss per share was -0.02.
| Revenue | 741,261 |
| Gross Profit | -4.53M |
| Operating Income | -6.68M |
| Pretax Income | -9.54M |
| Net Income | -8.91M |
| EBITDA | -6.62M |
| EBIT | -6.68M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 2.54 million in cash and n/a in debt, giving a net cash position of 2.54 million.
| Cash & Cash Equivalents | 2.54M |
| Total Debt | n/a |
| Net Cash | 2.54M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.71M |
| Book Value Per Share | 0.01 |
| Working Capital | 3.54M |
Cash Flow
In the last 12 months, operating cash flow was -5.38 million and capital expenditures -45,951, giving a free cash flow of -5.42 million.
| Operating Cash Flow | -5.38M |
| Capital Expenditures | -45,951 |
| Free Cash Flow | -5.42M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -900.98% |
| Pretax Margin | -1,287.11% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
genedrive does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -271.64% |
| Shareholder Yield | -271.64% |
| Earnings Yield | -76.04% |
| FCF Yield | -46.32% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
genedrive has an Altman Z-Score of -17.63 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -17.63 |
| Piotroski F-Score | 3 |